INDSWIFT LABORATORIES
|
INDSWIFT LABORATORIES Last 5 Year Balance Sheet History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
EQUITY AND LIABILITIES | |||||
Share Capital | ₹59 Cr | ₹60 Cr | ₹60 Cr | ₹60 Cr | ₹60 Cr |
Equity - Authorised | ₹60 Cr | ₹60 Cr | ₹60 Cr | ₹60 Cr | ₹60 Cr |
Equity - Issued | ₹59 Cr | ₹59 Cr | ₹59 Cr | ₹59 Cr | ₹59 Cr |
Equity Paid Up | ₹59 Cr | ₹59 Cr | ₹59 Cr | ₹59 Cr | ₹59 Cr |
Equity Shares Forfeited | - | ₹0.72 Cr | ₹0.72 Cr | ₹0.72 Cr | ₹0.72 Cr |
Adjustments to Equity | - | - | - | - | - |
Preference Capital Paid Up | - | - | - | - | - |
Face Value | ₹10.00 | ₹10.00 | ₹10.00 | ₹10.00 | ₹10.00 |
Share Warrants & Outstandings | - | - | - | - | - |
Total Reserves | ₹872 Cr | ₹622 Cr | ₹541 Cr | ₹544 Cr | ₹581 Cr |
Securities Premium | ₹307 Cr | ₹307 Cr | ₹307 Cr | ₹307 Cr | ₹307 Cr |
Capital Reserves | ₹-1.73 Cr | ₹-1.77 Cr | ₹-34 Cr | ₹-33 Cr | - |
Profit & Loss Account Balance | ₹392 Cr | ₹-29 Cr | ₹-78 Cr | ₹-76 Cr | ₹-74 Cr |
General Reserves | ₹177 Cr | ₹165 Cr | ₹152 Cr | ₹138 Cr | ₹123 Cr |
Other Reserves | ₹-2.05 Cr | ₹181 Cr | ₹194 Cr | ₹208 Cr | ₹224 Cr |
Reserve excluding Revaluation Reserve | ₹872 Cr | ₹439 Cr | ₹345 Cr | ₹333 Cr | ₹356 Cr |
Revaluation reserve | - | ₹183 Cr | ₹196 Cr | ₹211 Cr | ₹225 Cr |
Shareholder's Funds | ₹931 Cr | ₹682 Cr | ₹601 Cr | ₹604 Cr | ₹641 Cr |
Minority Interest | ₹-0.02 Cr | - | ₹-0.11 Cr | ₹-0.09 Cr | - |
Long-Term Borrowings | - | - | - | - | - |
Secured Loans | ₹11 Cr | ₹753 Cr | ₹848 Cr | ₹884 Cr | ₹886 Cr |
Non Convertible Debentures | - | ₹743 Cr | ₹797 Cr | ₹794 Cr | ₹776 Cr |
Converible Debentures & Bonds | ₹8.17 Cr | ₹8.17 Cr | - | ₹8.72 Cr | - |
Packing Credit - Bank | - | - | - | - | - |
Inter Corporate & Security Deposit | - | - | - | - | - |
Term Loans - Banks | - | - | - | - | - |
Term Loans - Institutions | - | - | - | - | - |
Other Secured | ₹3.00 Cr | ₹1.09 Cr | ₹51 Cr | ₹82 Cr | ₹110 Cr |
Unsecured Loans | - | - | - | - | ₹4.93 Cr |
Fixed Deposits - Public | - | - | - | - | ₹4.93 Cr |
Loans and advances from subsidiaries | - | - | - | - | - |
Inter Corporate Deposits (Unsecured) | - | - | - | - | - |
Foreign Currency Convertible Notes | - | - | - | - | - |
Long Term Loan in Foreign Currency | - | - | - | - | - |
Loans - Banks | - | - | - | - | - |
Loans - Govt. | - | - | - | - | - |
Loans - Others | - | - | - | - | - |
Other Unsecured Loan | - | - | - | - | - |
Deferred Tax Assets / Liabilities | ₹-32 Cr | ₹-30 Cr | ₹-52 Cr | ₹-60 Cr | ₹-78 Cr |
Deferred Tax Assets | ₹32 Cr | ₹74 Cr | ₹101 Cr | ₹134 Cr | ₹165 Cr |
Deferred Tax Liability | ₹0.44 Cr | ₹44 Cr | ₹49 Cr | ₹73 Cr | ₹87 Cr |
Other Long Term Liabilities | - | ₹0.66 Cr | ₹0.66 Cr | ₹0.66 Cr | ₹0.66 Cr |
Long Term Trade Payables | - | - | - | - | - |
Long Term Provisions | ₹1.23 Cr | ₹18 Cr | ₹17 Cr | ₹16 Cr | ₹15 Cr |
Total Non-Current Liabilities | ₹-19 Cr | ₹741 Cr | ₹814 Cr | ₹840 Cr | ₹828 Cr |
Current Liabilities | - | - | - | - | - |
Trade Payables | ₹94 Cr | ₹204 Cr | ₹176 Cr | ₹139 Cr | ₹135 Cr |
Sundry Creditors | ₹94 Cr | ₹204 Cr | ₹176 Cr | ₹139 Cr | ₹135 Cr |
Acceptances | - | - | - | - | - |
Due to Subsidiaries- Trade Payables | - | - | - | - | - |
Other Current Liabilities | ₹23 Cr | ₹106 Cr | ₹89 Cr | ₹81 Cr | ₹73 Cr |
Bank Overdraft / Short term credit | - | - | - | - | - |
Advances received from customers | ₹5.35 Cr | ₹15 Cr | ₹15 Cr | ₹18 Cr | ₹9.35 Cr |
Interest Accrued But Not Due | ₹2.75 Cr | ₹9.58 Cr | ₹10.00 Cr | - | - |
Share Application Money | - | - | - | - | - |
Current maturity of Debentures & Bonds | - | - | - | - | - |
Current maturity - Others | - | - | - | - | - |
Other Liabilities | ₹15 Cr | ₹81 Cr | ₹64 Cr | ₹63 Cr | ₹64 Cr |
Short Term Borrowings | ₹2.71 Cr | ₹49 Cr | ₹64 Cr | ₹93 Cr | ₹115 Cr |
Secured ST Loans repayable on Demands | - | ₹45 Cr | ₹59 Cr | ₹61 Cr | ₹62 Cr |
Working Capital Loans- Sec | - | ₹45 Cr | ₹59 Cr | ₹61 Cr | ₹62 Cr |
Buyers Credits - Unsec | - | - | - | - | - |
Commercial Borrowings- Unsec | - | - | - | - | - |
Other Unsecured Loans | ₹2.71 Cr | ₹-40 Cr | ₹-55 Cr | ₹-28 Cr | ₹-9.76 Cr |
Short Term Provisions | ₹102 Cr | ₹12 Cr | ₹5.39 Cr | ₹0.98 Cr | - |
Proposed Equity Dividend | - | - | - | - | - |
Provision for Corporate Dividend Tax | - | - | - | - | - |
Provision for Tax | ₹102 Cr | ₹12 Cr | ₹5.39 Cr | ₹0.98 Cr | - |
Provision for post retirement benefits | - | - | - | - | - |
Preference Dividend | - | - | - | - | - |
Other Provisions | - | - | - | - | - |
Total Current Liabilities | ₹221 Cr | ₹371 Cr | ₹334 Cr | ₹315 Cr | ₹323 Cr |
Total Liabilities | ₹1,133 Cr | ₹1,794 Cr | ₹1,749 Cr | ₹1,758 Cr | ₹1,792 Cr |
ASSETS | |||||
Gross Block | ₹8.15 Cr | ₹1,331 Cr | ₹1,317 Cr | ₹1,302 Cr | ₹1,359 Cr |
Less: Accumulated Depreciation | ₹2.79 Cr | ₹746 Cr | ₹689 Cr | ₹563 Cr | ₹516 Cr |
Less: Impairment of Assets | - | - | - | - | - |
Net Block | ₹5.36 Cr | ₹585 Cr | ₹628 Cr | ₹739 Cr | ₹843 Cr |
Lease Adjustment A/c | - | - | - | - | - |
Capital Work in Progress | - | ₹7.71 Cr | ₹9.31 Cr | ₹11 Cr | ₹3.80 Cr |
Non Current Investments | ₹111 Cr | ₹30 Cr | ₹29 Cr | ₹36 Cr | ₹17 Cr |
Long Term Investment | ₹111 Cr | ₹30 Cr | ₹29 Cr | ₹36 Cr | ₹17 Cr |
Quoted | - | - | - | - | - |
Unquoted | ₹111 Cr | ₹30 Cr | ₹29 Cr | ₹36 Cr | ₹17 Cr |
Long Term Loans & Advances | ₹354 Cr | ₹4.17 Cr | ₹3.96 Cr | ₹6.11 Cr | ₹57 Cr |
Other Non Current Assets | - | - | - | - | - |
Total Non-Current Assets | ₹472 Cr | ₹630 Cr | ₹674 Cr | ₹814 Cr | ₹929 Cr |
Current Assets Loans & Advances | - | - | - | - | - |
Currents Investments | - | - | - | - | - |
Quoted | - | - | - | - | - |
Unquoted | - | - | - | - | - |
Inventories | ₹10 Cr | ₹439 Cr | ₹429 Cr | ₹376 Cr | ₹343 Cr |
Raw Materials | ₹0.22 Cr | ₹108 Cr | ₹108 Cr | ₹94 Cr | ₹82 Cr |
Work-in Progress | - | ₹189 Cr | ₹191 Cr | ₹166 Cr | ₹171 Cr |
Finished Goods | ₹10 Cr | ₹128 Cr | ₹117 Cr | ₹107 Cr | ₹81 Cr |
Packing Materials | - | - | - | - | - |
Stores  and Spare | - | ₹13 Cr | ₹11 Cr | ₹9.18 Cr | ₹8.21 Cr |
Other Inventory | - | - | - | - | - |
Sundry Debtors | ₹169 Cr | ₹505 Cr | ₹455 Cr | ₹432 Cr | ₹396 Cr |
Debtors more than Six months | - | - | - | - | - |
Debtors Others | ₹169 Cr | ₹505 Cr | ₹455 Cr | ₹432 Cr | ₹396 Cr |
Cash and Bank | ₹432 Cr | ₹18 Cr | ₹21 Cr | ₹12 Cr | ₹11 Cr |
Cash in hand | ₹1.47 Cr | ₹0.78 Cr | ₹0.20 Cr | ₹0.52 Cr | ₹0.30 Cr |
Balances at Bank | ₹430 Cr | ₹17 Cr | ₹21 Cr | ₹11 Cr | ₹10 Cr |
Other cash and bank balances | - | - | - | - | - |
Other Current Assets | - | ₹9.02 Cr | ₹17 Cr | ₹56 Cr | ₹39 Cr |
Interest accrued on Investments | - | - | - | - | - |
Interest accrued on Debentures | - | - | - | - | - |
Deposits with Government | - | - | - | - | - |
Interest accrued and or due on loans | - | - | - | - | - |
Prepaid Expenses | - | ₹4.07 Cr | ₹5.03 Cr | ₹2.18 Cr | ₹1.33 Cr |
Other current_assets | - | ₹4.95 Cr | ₹12 Cr | ₹54 Cr | ₹37 Cr |
Short Term Loans and Advances | ₹50 Cr | ₹192 Cr | ₹152 Cr | ₹66 Cr | ₹74 Cr |
Advances recoverable in cash or in kind | ₹59 Cr | ₹61 Cr | ₹48 Cr | ₹53 Cr | ₹11 Cr |
Advance income tax and TDS | ₹6.07 Cr | ₹4.96 Cr | ₹4.55 Cr | ₹4.06 Cr | ₹3.98 Cr |
Amounts due from directors | - | - | - | - | - |
Due From Subsidiaries | - | - | - | - | - |
Inter corporate deposits | - | - | - | - | - |
Corporate Deposits | - | - | - | - | - |
Other Loans & Advances | ₹-15 Cr | ₹126 Cr | ₹99 Cr | ₹8.47 Cr | ₹60 Cr |
Total Current Assets | ₹661 Cr | ₹1,163 Cr | ₹1,073 Cr | ₹942 Cr | ₹863 Cr |
Net Current Assets (Including Current Investments) | ₹440 Cr | ₹792 Cr | ₹739 Cr | ₹627 Cr | ₹540 Cr |
Miscellaneous Expenses not written off | - | - | - | - | - |
Total Assets | ₹1,133 Cr | ₹1,794 Cr | ₹1,749 Cr | ₹1,758 Cr | ₹1,792 Cr |
Contingent Liabilities | ₹1.36 Cr | ₹4.24 Cr | ₹36 Cr | ₹40 Cr | ₹23 Cr |
Total Debt | ₹14 Cr | ₹852 Cr | ₹943 Cr | ₹1,005 Cr | ₹1,031 Cr |
Book Value | 157.64 | 84.25 | 68.33 | 66.35 | 70.21 |
Adjusted Book Value | 157.64 | 84.25 | 68.33 | 66.35 | 70.21 |
Compare Balance Sheet of peers of INDSWIFT LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
INDSWIFT LABORATORIES | ₹639.0 Cr | -4% | 4.1% | 11.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹433,920.0 Cr | -0.1% | 1.7% | 45.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹155,160.0 Cr | -0.1% | -2.2% | 56.9% | Stock Analytics | |
CIPLA | ₹118,917.0 Cr | 1.7% | 0.5% | 23.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹112,017.0 Cr | 5.7% | 12.4% | 18.5% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹97,997.1 Cr | -1.4% | 3.1% | 44.8% | Stock Analytics |
INDSWIFT LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
INDSWIFT LABORATORIES | -4% |
4.1% |
11.5% |
SENSEX | -5% |
0.6% |
9.2% |
You may also like the below Video Courses